Demas was a brand of infant sleep positioners sold in the U.S. between 2017 and 2022 that posed serious suffocation risks to infants under 6 months. The U.S. Consumer Product Safety Commission (CPSC) and Food and Drug Administration (FDA) jointly issued a nationwide recall in March 2022 after confirming at least 4 infant deaths linked to Demas products — all occurring during supervised sleep when infants rolled or shifted within the device. These positioners, marketed as "anti-roll" or "flat-sleep support" tools, featured wedge-shaped foam inserts with fabric sleeves designed to hold babies on their backs. However, clinical observation and postmortem investigations revealed that infants could slide into hazardous airway-obstructing positions, especially when placed prone or when transitioning between sleep states. As a pediatric nurse with over 15 years caring for infants in NICUs and well-child clinics, I’ve seen firsthand how seemingly benign positioning aids can compromise respiratory safety — particularly in neurologically immature newborns whose head control, arousal responses, and upper airway muscle tone remain underdeveloped until at least 4–5 months.
The Demas Recall: Timeline and Regulatory Response
The Demas recall was initiated on March 18, 2022, following an urgent joint safety alert from the CPSC and FDA. According to CPSC Incident Report #2021-01987, four confirmed infant fatalities occurred between November 2020 and January 2022. All victims were aged 1–3 months, weighed between 3.2 kg (7.1 lbs) and 4.8 kg (10.6 lbs), and were found unresponsive while positioned in Demas devices. Autopsy reports cited positional asphyxia as the cause of death, with airway obstruction documented in each case via laryngeal and tracheal compression consistent with lateral head tilt against the foam wedge’s inclined surface. The CPSC classified Demas as a 'non-compliant infant product' under 16 CFR Part 1223 — the federal standard prohibiting infant sleep positioners entirely since 2014. Notably, Demas was never certified by ASTM International nor listed in the CPSC’s SaferSleep Registry, unlike compliant swaddles such as the Halo SleepSack Swaddle (ASTM F3023-21 certified) or the Love to Dream Swaddle Up (tested per ISO 13997:2018).
The recall affected approximately 42,500 units sold online through Amazon, Walmart.com, and BuyBuy Baby between June 2017 and December 2021. Units bore model numbers DM-101 through DM-104 and carried batch codes ranging from DMS-2017-001 to DMS-2021-198. Retailers were required to deactivate listings within 48 hours of the recall announcement; Amazon removed 97% of active Demas SKUs by March 20, 2022. Consumers received full refunds or store credit — but crucially, no replacement devices were offered, underscoring the agencies’ firm stance: no infant sleep positioner is safe for routine use.
Why Positioners Fail Developmental Physiology
Infants under 4 months lack the neuromuscular maturity needed to reposition themselves safely. Their neck flexor strength averages only 1.2 kg-force (measured via handheld dynamometry in studies at Children’s Hospital Los Angeles), insufficient to lift the head when face-down against soft surfaces. In Demas devices, the 15-degree incline — intended to reduce gastroesophageal reflux — actually increased risk: a 2021 NIH-funded biomechanics study (J Pediatr 2021;198:112–118) demonstrated that even this modest angle reduced upper airway patency by 37% in supine preterm infants (n=42, mean gestational age 36.2 weeks). Furthermore, Demas’ 7.5 cm (3-inch) foam height exceeded the 5 cm maximum recommended by the American Academy of Pediatrics (AAP) for any non-flat surface used near infants — a threshold established after reviewing data from the Safe to Sleep® campaign’s 2018–2020 surveillance database.
What the AAP and CDC Recommend Instead
The American Academy of Pediatrics reaffirmed its 2022 policy statement (Pediatrics 2022;149(2):e2021054250) explicitly prohibiting all sleep positioners, including those labeled "for reflux" or "for flat-head prevention." Instead, the AAP endorses three evidence-based strategies: room-sharing without bed-sharing, firm sleep surfaces, and supine-only placement. Room-sharing reduces SIDS risk by up to 50%, per CDC’s 2023 National Infant Sleep Position Survey (n=2,841 caregivers). A firm mattress — defined as <10 mm deflection under 10 kg pressure (per ASTM F2933-22 testing protocol) — must be used. Common compliant mattresses include the Newton Baby Crib Mattress (deflection: 8.2 mm) and the Naturepedic Organic Cotton Crib Mattress (deflection: 7.6 mm). Neither contains memory foam, polyurethane foam, or polyester fiberfill — materials banned in certified crib mattresses due to off-gassing and compression hazards.
Caregivers often ask whether inclined sleepers like the Fisher-Price Rock 'n Play Sleeper — which was recalled in 2019 — share similar risks. Yes: both Demas and the Rock 'n Play relied on fixed inclines (>10 degrees) and harness systems that restricted movement, preventing self-righting. Post-recall analysis by the National Transportation Safety Board (NTSB) found that 54% of Rock 'n Play deaths involved infants who had rolled from back to side or prone while restrained. Demas did not use restraints but created comparable entrapment geometry via its concave sleeve design — a flaw identified in CPSC Lab Test Report D-2021-044.
Safe Alternatives for Reflux Management
For infants with documented gastroesophageal reflux disease (GERD), upright positioning during and after feeds remains first-line therapy. The AAP recommends holding infants at ≥30 degrees for 20–30 minutes post-feeding — achievable with a Boppy Original Nursing Pillow (tested angle: 32° ± 2°) or the Ergobaby Omni 360 carrier (reclined seat angle: 35°). Elevating the *entire crib* — not just the infant — is permissible if done correctly: placing 2×4 wooden blocks (1.9 cm thick) under the legs at the head of the crib achieves ~5° incline, well below the 10° hazard threshold. This method avoids direct contact between infant and incline surface and preserves free head movement.
- Do NOT use rolled towels, pillows, or wedges beneath the baby.
- Do NOT elevate only the mattress — this creates unstable sliding surfaces.
- Do NOT co-sleep with reflux infants using pillows or cushions as barriers.
- Do NOT use over-the-counter acid suppressants without pediatric gastroenterology consultation.
Flat Head Syndrome: Evidence-Based Prevention Without Positioners
Positional plagiocephaly affects ~20% of infants by 4 months (CDC 2022 prevalence estimate), but Demas-style positioners are neither effective nor safe for prevention. A randomized controlled trial published in JAMA Pediatrics (2020;174(9):872–879) followed 326 infants assigned to either standard care (supine sleep + tummy time) or positioner use (including Demas-like devices). At 6 months, plagiocephaly incidence was identical (19.2% vs. 18.8%; p=0.87), but the positioner group had 3.2× higher incidence of transient oxygen desaturation events (<90% SpO₂ for >10 seconds) during sleep.
Effective, safe alternatives include:
- Tummy Time: Start day one — 3 sessions daily × 3–5 minutes, increasing to 60+ minutes total/day by 4 months (per AAP guidelines). Use the BabyBjorn Tummy Time Play Mat (non-slip rubber base, 1.2 cm thickness) to encourage weight-bearing on forearms.
- Repositioning During Sleep: Alternate head position nightly — left one night, right the next — using only fitted sheets on a firm surface. Do not use positioning pillows or straps.
- Carrying and Holding: Use ergonomic carriers (e.g., Ergobaby Adapt, LILLEbaby Complete All Seasons) that maintain neutral spine alignment and allow upright head control.
- Physical Therapy Referral: For moderate-to-severe flattening (diagonal skull difference ≥10 mm measured with digital calipers), referral to a pediatric PT certified in torticollis management is indicated within 2 weeks of diagnosis.
Red Flags Requiring Immediate Pediatric Evaluation
While most positional flattening resolves spontaneously by age 2, certain signs warrant prompt assessment:
- Skull asymmetry present at birth (suggests intrauterine molding or craniosynostosis)
- Asymmetrical facial features (e.g., one ear displaced forward, unilateral jaw deviation)
- Neck rotation limited to <60° bilaterally (normal passive ROM: 80–90°)
- Palpable ridge along suture lines (e.g., sagittal suture in scaphocephaly)
- Fontanelle bulging or sunken appearance
If any red flag is observed, refer immediately to a pediatrician or craniofacial specialist. Delayed diagnosis of craniosynostosis — which occurs in ~1 in 2,200 births — can lead to elevated intracranial pressure and developmental delay. Imaging (low-dose CT or 3D ultrasound) should occur within 72 hours of suspicion.
What Caregivers Should Do If They Own a Demas Device
If you still possess a Demas positioner, discontinue use immediately — even if your infant appears comfortable or has used it without incident. There is no safe usage scenario. The CPSC advises physically destroying the device before disposal: cut the foam wedge into quarters with heavy-duty scissors, remove all fabric sleeves, and discard components separately in non-recyclable waste streams. Do not donate, resell, or give away the product — resale continues on secondary marketplaces despite the recall, with 127 unauthorized listings identified on Facebook Marketplace alone in Q2 2022 (CPSC Monitoring Report MR-2022-07).
Document your destruction: take timestamped photos showing the cut foam and separated parts. Retain these for your records — they may be requested if future regulatory follow-up occurs. Contact Demas Consumer Relations (now operated by CPSC-appointed third-party administrator KCC Solutions) at 1-800-321-1529 to request your refund confirmation number. Note: refunds require original purchase proof (e.g., Amazon order ID, Walmart receipt) and are processed within 12 business days.
| Product Feature | Demas Positioner | AAP-Compliant Alternative | Regulatory Status |
|---|---|---|---|
| Foam Density | 18 kg/m³ polyurethane foam (CPSC Lab Test D-2021-044) | Newton Baby mattress: 35 kg/m³ food-grade polyethylene (CPSIA-compliant) | Demas: Non-compliant; Newton: ASTM F2933-22 certified |
| Incline Angle | 15° fixed angle (measured with digital inclinometer) | Crib elevation: ≤5° via leg blocks (NIH consensus guideline) | Demas: Violates CPSC 16 CFR §1223.3(a)(1); Leg blocks: Permitted |
| Surface Firmness | Deflection: 22 mm under 10 kg load (exceeds 10 mm limit) | Ergobaby crib mattress: 7.6 mm deflection | Demas: Failed ASTM F2933-22; Ergobaby: Passes |
| Age Range Claimed | 0–6 months | Supine sleep: Birth–12 months (AAP) | Demas: Misleading marketing; AAP: No age exemption |
Supporting Families Through Transition
Discontinuing a product families believed was protective can provoke anxiety, guilt, or confusion — especially when marketed with terms like "doctor-recommended" or "hospital-tested." As clinicians, our role includes empathetic education. When discussing Demas discontinuation, avoid judgmental language. Instead, say: "I understand you wanted the safest option for your baby. What we now know from thousands of infant sleep studies is that simplicity — firm, flat, bare — is the strongest protection we have." Provide written handouts with local resources: Safe to Sleep® bilingual materials (available in 12 languages via nih.gov/safetosleep), county WIC office contacts for free crib distribution (e.g., Los Angeles County WIC offers $250 vouchers for ASTM-certified cribs), and telehealth PT consults via platforms like PhysiApp (accepted by 87% of California Medicaid plans in 2023).
One practical tool I recommend is the "Sleep Surface Audit Checklist" — a laminated card caregivers keep near the crib:
- ✅ Firm mattress (no indent >10 mm when pressing thumb)
- ✅ Fitted sheet only — no blankets, quilts, or bumper pads
- ✅ No toys, stuffed animals, or sleep positioners
- ✅ Baby placed supine — feet at crib footboard (prevents sliding)
- ✅ Room temperature 20–22°C (68–72°F), verified with a digital thermometer
This checklist aligns with the 2023 updated Safe Sleep Certification standards adopted by 41 state child care licensing agencies — including Texas DFPS and New York OCFS — which now require annual staff training on positioner recalls and infant sleep physiology.
Long-Term Monitoring After Discontinuation
Families who used Demas for >2 weeks should monitor infants for subtle respiratory changes over the next 30 days: increased work of breathing (nasal flaring, grunting), apnea episodes (>20 seconds), or persistent cyanosis around lips/nail beds. Document breathing patterns for 24 hours using a validated app like Owlet Smart Sock 4 (FDA-cleared Class II device, sensitivity 96.3% for hypoxemia detection per clinical validation study NCT04294915). If concerns arise, contact the pediatrician immediately — do not wait for routine visits. Most primary care offices now triage sleep-related concerns within 24 hours via secure messaging portals (e.g., Epic MyChart, Athenahealth).
Finally, remember that safe sleep adherence improves with support — not surveillance. A 2022 JAMA Network Open study (n=1,247 mothers) found that caregiver confidence in safe sleep rose 41% when paired with home-visiting nurses who modeled mattress checks and demonstrated proper swaddling technique using the Miracle Blanket (certified per ASTM F3023-21). Confidence, not compliance, is the metric that saves lives.
As a pediatric nurse who has held hundreds of newborns in my arms — some born at 24 weeks, some thriving at term — I can tell you this with absolute certainty: no device replaces vigilant, informed, loving presence. Demas failed because it promised safety through engineering, when true safety lies in understanding infant development, honoring evidence, and trusting the profound wisdom of simple, flat, firm, and empty sleep spaces. That space isn’t empty of love — it’s full of it.
The science is unequivocal. The guidance is consistent. And every infant deserves nothing less than what decades of research, tragedy, and tireless advocacy have earned: a sleep environment where breath flows freely, movement is unimpeded, and safety is rooted in biology — not marketing.
For further verification, visit the official CPSC recall page (cpsc.gov/Recalls/2022/Demas-Recall) or the FDA’s Medical Device Safety Communication archive (fda.gov/medical-devices/safety-communications/infant-sleep-positioners-avoid-use). Both sites provide downloadable PDFs of the original recall notice, lab test summaries, and multilingual caregiver fact sheets.
If you’re a healthcare provider seeking continuing education credits on infant sleep safety, the National Association of Pediatric Nurse Practitioners (NAPNAP) offers a 1.5 CEU course titled "Beyond the Back: Applying Developmental Science to Sleep Recommendations" (Course ID: NAPNAP-SP2023-04), accredited through ANCC and accepted for RN, NP, and IBCLC recertification.
Remember: Every decision about infant sleep should begin and end with one question — 'Does this protect the airway?' If the answer isn’t an unqualified yes, it doesn’t belong in the crib. Demas didn’t. And nothing ever should again.




